top of page

Gertrude Elion

ELION, Gertrude (Belle), American biochemist, 1918-1999. A research scientist at the Burroughs Wellcome Labs from 1944. The drug 6-MP was synthesised by her in 1950. This drug (6-mercaptopurine, Imuran), also known as allopurinol, aided successful organ transplantation, especially in kidneys. It stopped kidney blockage in cancer patients on chemotherapy and radiotherapy, it was also the drug of choice in gout. From 1967 she was the Director of Experimental Therapy. Gertrude was awarded the Garvan Medal in 1968. Then, in 1974, she created the drug aciclovir for treatment of Herpes virus infection. The antileukaemic drug, (6-MP), as used in chemotherapy, had by then turned out to be very important. Her work over 30 years resulted in the creation of a great many valuable new drugs. Finally in 1983, her group produced the drug AZT (azidothymidine) designed to treat AIDS, this success came within the first year of her retirement. Gertrude was awarded the 1988 Nobel Prize in Medicine for her work on vital new drugs. Her election into the Inventors Hall of Fame (HOF) in 1991 was for creating DNA-blocking drugs for anti-Cancer treatment, She was the first of only four women in (HOF). Elected a member of the NAS in 1991 and also awarded the National Medal of Science. Gertrude is named on 45 new drug patents.

Biochemist & Inventor

Back To:

Related further reading...

Further Reading:

  • facebook
  • Twitter Clean
  • w-googleplus
IW 0101.png
IW 0201.png
IW 0301.png
IW 0401.png
IW 0501.png
IW 0601.png
IW 0701.png
IW 0801.png
IW 0901.png
IW 1001.png
IW 1101.png
IW 1201.png
IW 1301.png
IW 1401.png

© inventricity.com 2014,2015 - 2016

Warning - We are always delighted to receive information from inventors and companies regarding their wonderful inventions.  However, please do not send us confidential information.  You should not disclose your ideas or inventions before either taking professional advice, or stipulating a binding and specific confidentiality agreement, or filing a patent application at the Intellectual Property Office.  Inventors who disclose the details of their invention before filing will not be able to obtain a valid patent.  This advice applies to any disclosure, no matter how select or reputable the agency.  You should not talk to the press, radio, television or any other media, nor should you enter into competitions/exhibitions, or give lectures/presentations without adequate Intellectual Property Protection.

 

Articles and information produced on this site are concerned with general principles only and should not be construed as specific advice.  Intellectual Property Rights and their commercial development are complex subjects and professional advice should always be sought at the appropriate stage.  Procedures and regulations vary from country to country.  Opinions expressed are those of the individual contributors and not necessarily those of Inventricity.com                                                                                                                                                                                                                                               Disclaimer

bottom of page